Pfizer's Q4 earnings put a small scare into investors a couple weeks back, but the pharma behemoth is built too well to ignore. More
-
-
Sponsored By:
-
Sponsored By:
AZN
Recent Articles
How Netflix (And 14 Other Blue Chips) Got Its Groove Back
Here is a list of 15 companies that have turned their businesses around, led by Netflix, which is now humming along with profitability and a soaring stock price More
3 New Dividend Funds Let You ‘Pick Your Risk’
FlexShares' new trio of "Quality" dividend ETFs allows you to "pick your risk profile," but still doesn't seem to add much spice to the dividend-fund world. More
6 Call Contenders: Pharmaceuticals
My Power Stock scanner has identified bullish trends for these 6 stocks, all trading near their support. It's the perfect time to initiate a long position or at-the-money calls. More
3 Generic Drug Stocks to Buy Right Away
Generic drugs are forecast to be the single fastest-growing industry for the next several years. Here are three stocks to profit from this trend. More
India Drops Patent Bomb on Novartis
India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma. More
46 Stock Bellwethers on the Move
There is no doubt the upcoming first-quarter earnings announcement season is going to separate the wheat from the chaff and here are 46 stocks with new ratings More
